Back close

Low Cost Device and Cloud Enabled Smart Solution for Diabetes Care

Start Date: Tuesday, Jun 23,2015

Funded by:DBT
Low Cost Device and Cloud Enabled Smart Solution for Diabetes Care

In a unique partnership, Amrita Vishwa Vidyapeetham joined hands with Wipro Technologies, Bangalore to work on an end-to-end diabetes solution. The project entitled “Low Cost Device and Cloud Enabled Smart Solution for Diabetes Care” is funded by DBT-BIRAC, Government of India. The project utilizes the patented Automated Insulin Pump as well as the novel non-enzymatic glucose monitoring system developed by Amrita and linked via a mobile application developed by Wipro Technologies. Data from patients utilizing these devices would be transferred via the mobile app to a cloud and dedicated server hosted by Wipro, thus providing an interface between a diabetic patient and a 24×7 diabetes helpline, endocrinologists and care-giver. This project on completion holds tremendous potential to healthcare for the 65 million diabetic patients in India today.

Related Projects

Schiff’s Base Derivative Of Chitosan: A Potential Matrix For Metalloprotein Enrichment
Schiff’s Base Derivative Of Chitosan: A Potential Matrix For Metalloprotein Enrichment
Development of New and Efficient Photo Sensitizer for Dye Solar Cell
Development of New and Efficient Photo Sensitizer for Dye Solar Cell
Amrita Automotive Technology Center (AATC)
Amrita Automotive Technology Center (AATC)
Fiber Optics Technology in Landslide Prone Areas
Fiber Optics Technology in Landslide Prone Areas
Tetracycline Augments the Anti-biofilm Potential of Essential Oils and D-Amino Acids Against Pseudomonas Aeruginosa
Tetracycline Augments the Anti-biofilm Potential of Essential Oils and D-Amino Acids Against Pseudomonas Aeruginosa
Admissions Apply Now